Abstract:Since the ataxia telangiectasia mutated (ATM) protein plays crucial roles in repair of double-stranded DNA breaks, control of cell cycle checkpoints, and radiosensitivity, we hypothesized that variations in this gene might be associated with esophageal squamous cell carcinoma(ESCC)radiation response. A total of 243 ESCC patients receiving preoperative radiation therapy (RT) between 1980 and 2007 were included in this study. RT was administered as conventional simulation to the anterior and posterior fields for about DT 40 Gy/20F/4 wks. Patients underwent esophagectomy approximately 4-8 weeks after RT. Tumor regression grade(TRG) was used to grade radiation response. Grade 1, complete (0% residual tumor; Grade 1a) or subtotal tumor regression (<10% residual tumor per tumor bed; Grade 1b); Grade 2, partial tumor regression (10-50% residual tumor per tumor bed), and Grade 3, minimal or no tumor regression (>50% residual tumor per tumor bed). Four haplotype-tagging single nucleotide polymorphisms (SNPs) in the ATM gene were genotyped by the Sequenom MassARRAY system. For pathologic response to radiation, multivariate logistic regression analysis was done to estimate adjusted odds ratios (ORs) along with the corresponding 95% confidence intervals (CIs) for each polymorphism. The median follow-up time was 28.4 month. After radiation therapy,TRG1-3 rate were 38.7% (n = 94), 35.8% (n = 87), 25.5% (n = 62). In multivariate Cox regression models adjusted for other clinical predictors, ATM-111G>A and 49238 T>C variants were independently associated with radiosensitivity. Comparing TRG2-3, ATM-111AA genotype was associated significantly with TRG1 than AG genotype (adjusted OR = 0.53; 95% CI = 0.29-0.97; p = 0.039) or AG + GG genotype (adjusted OR = 0.52; 95% CI = 1.16-5.28; p = 0.018). Comparing TRG1, ATM 49238CC genotype was associated significantly with TRG3 than CC + TT genotype (adjusted OR = 2.00; 95% CI = 0.92-4.34; p = 0.079). All ATM SNPs were not significantly associated with improved survival and recurrence risk. This study strongly suggest the polymorphisms of ATM-111 G>A and ATM 49238 T>C should be useful as two potential predictive biomarkers of radiation therapy response in esophageal cancer patients treated with preoperative radiation therapy.

Genetic polymorphism contributes to 131 I radiotherapy-induced toxicities in patients with differentiated thyroid cancer.

Genetic polymorphism contributes to <sup>131</sup>I radiotherapy-induced toxicities in patients with differentiated thyroid cancer

ATM Polymorphisms Are Associated with Radiosensitivity for Patients with Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiation Therapy

Vitamin D receptor polymorphisms associate with the efficacy and toxicity of radioiodine-131 therapy in patients with differentiated thyroid cancer

Association Between Single Nucleotide Polymorphisms (Snps) And Toxicity Of Advanced Non-Small-Cell Lung Cancer Patients Treated With Chemotherapy

Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients

Relationship Between Single Nucleotide Polymorphisms and the Toxicy and Side Effects of Paclitaxel and Platinum-Based Chemotherapy in Patients with Malignant Tumors

Tnf Rs1799964 As A Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patient Treated with Chemoradiation Therapy

Genetic Polymorphisms and Treatment Response in Advanced Non-Small Cell Lung Cancer.

Inflammation-related Genetic Variants Predict Toxicity Following Definitive Radiotherapy for Lung Cancer.

The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.

XRCC1 Gene Polymorphisms and the Risk of Differentiated Thyroid Carcinoma (DTC): A Meta-Analysis of Case-Control Studies

A Two-Stage Genome-Wide Association Study to Identify Novel Genetic Loci Associated with Acute Radiotherapy Toxicity in Nasopharyngeal Carcinoma.

Single Nucleotide Polymorphisms in APE1, hOGG1, RAD51 Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients

Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra

ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients

[Genetic Polymorphisms in X-ray Repair Cross-Complementing Gene 1 and Susceptibility to Papillary Thyroid Carcinoma].

Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer

The Association of Genetic Variations in DNA Repair Pathways with Severe Toxicities in NSCLC Patients Undergoing Platinum-Based Chemotherapy.

The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma.